Outfitter Advisors’s TherapeuticsMD TXMD Stock Holding History

Outfitter Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$322K	Hold	1,031	–	–	0.15%	96
2018 Q1	$251K	Hold	1,031	–	–	0.11%	109
2017 Q4	$311K	Hold	1,031	–	–	0.1%	111
2017 Q3	$273K	Hold	1,031	–	–	0.1%	112
2017 Q2	$272K	Hold	1,031	–	–	0.1%	110
2017 Q1	$371K	Sell	1,031 -200	-16%	-$61.9K	0.14%	104
2016 Q4	$355K	Hold	1,231	–	–	0.14%	101
2016 Q3	$419K	Hold	1,231	–	–	0.17%	95
2016 Q2	$523K	Sell	1,231 -40	-3%	-$16.5K	0.22%	90
2016 Q1	$407K	Hold	1,271	–	–	0.16%	101
2015 Q4	$659K	Hold	1,271	–	–	0.26%	86
2015 Q3	$372K	Hold	1,271	–	–	0.16%	109
2015 Q2	$499K	Sell	1,271 -940	-43%	-$332K	0.19%	100
2015 Q1	$669K	Sell	2,211 -205	-8%	-$50K	0.25%	89
2014 Q4	$538K	Hold	2,416	–	–	0.21%	96
2014 Q3	$561K	Sell	2,416 -1,200	-33%	-$302K	0.22%	93
2014 Q2	$799K	Sell	3,616 -2,829	-44%	-$630K	0.3%	83
2014 Q1	$2.03M	Sell	6,445 -225	-3%	-$71.6K	0.8%	43
2013 Q4	$1.74M	Sell	6,670 -230	-3%	-$50.4K	0.69%	50
2013 Q3	$1.01M	Sell	6,900 -237	-3%	-$28.7K	0.42%	70
2013 Q2	$1.08M	Buy	+7,137	New	+$978K	0.5%	66

Other funds holding TXMD

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Outfitter Advisors's TXMD Position: Q2 2018 in Review

Outfitter Advisors held its TherapeuticsMD (TXMD) position steady in Q2 2018 at 1,031 shares worth $322K. The position accounts for 0.15% of the portfolio, ranked #96.

Outfitter Advisors first reported a position in TXMD in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.03M in Q1 2014. 144 funds tracked by Wall St. Rank hold TXMD as of Q2 2018.

Outfitter Advisors held 1,031 shares of TherapeuticsMD worth $322K as of Q2 2018.
Outfitter Advisors left its TherapeuticsMD share count unchanged in Q2 2018.
TherapeuticsMD made up 0.15% of Outfitter Advisors's portfolio in Q2 2018, its #96 holding.
Outfitter Advisors first reported a position in TherapeuticsMD in Q2 2013 and has held it in 21 quarters since.
Outfitter Advisors's TherapeuticsMD position peaked at $2.03M in Q1 2014.
144 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2018.

Based on Outfitter Advisors's 13F filing for Q2 2018, filed 23 Jul 2018.